A critical advance in cancer study is arising with the use of mini-antibodies to reactivate mutated p53. This crucial malignant protector protein is frequently lost in many kinds of cancer, resulting uncontrolled https://bookmarklayer.com/story21998837/vhh-fragments-revive-p53-a-new-pathway-for-malignant-treatment